LINC02126: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC02126

NCBI ID: G101927650

LINC02126

Other Name(s): Long intergenic non-protein coding RNA 2126 | long intergenic non-protein coding RNA 2126

LINC02126: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

LINC02126 is a long non-protein-coding RNA (lncRNA) that has been identified in various studies as having important functional roles in various cellular processes. Its unique structure and function have made it an attractive target for drug development and research into new biomarkers. In this article, we will explore the potential of LINC02126 as a drug target and its potential as a biomarker for various diseases.

Potential Drug Target

The drug development process typically begins with the identification of potential targets. In the case of LINC02126, its unique structure and function as a non-coding RNA have made it an attractive target for drug development. LINC02126 has been shown to play a role in various cellular processes, including cell adhesion, migration, and survival.

Additionally, LINC02126 has been shown to interact with several protein tyrosine kinases, including TAK-2 and Src/FAK. This interaction suggests that LINC02126 may be a useful drug target for treating diseases that are characterized by the over-activation of these kinases.

Potential Biomarker

LINC02126 has also been shown to be a potential biomarker for several diseases. Its unique structure and function as a non-coding RNA have make it an attractive target for diagnostic assays.

In cancer, LINC02126 has been shown to be overexpressed in various tissues and has been associated with cancer progression. This suggests that LINC02126 may be a useful biomarker for cancer diagnosis and treatment.

In addition to its potential as a cancer biomarker, LINC02126 has also been shown to be involved in several other biological processes, including cell signaling and inflammation. This suggests that LINC02126 may be a useful biomarker for a variety of diseases.

Conclusion

In conclusion, LINC02126 is a long non-protein-coding RNA that has been identified in various studies as having important functional roles in various cellular processes. Its unique structure and function have made it an attractive target for drug development and research into new biomarkers. Additionally, LINC02126 has been shown to be a potential drug target for treating diseases characterized by the over-activation of protein tyrosine kinases. As a potential biomarker, LINC02126 may be useful for the diagnosis and treatment of a variety of diseases. Further research is needed to fully understand the unique functions of LINC02126 and its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2126

The "LINC02126 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02126 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets